WebOct 22, 2024 · The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma Front Oncol. 2024 Oct 22;11:761379. doi: 10.3389/fonc.2024.761379. eCollection 2024. Authors
Molecules Free Full-Text Enhancement of Cisplatin Cytotoxicity …
WebOct 5, 2014 · Cisplatin, cisplatinum, or cis -diamminedichloroplatinum (II), is a well-known chemotherapeutic drug. It has been used for treatment of numerous human cancers including bladder, head and neck, lung, ovarian, and testicular cancers. It is effective against various types of cancers, including carcinomas, germ cell tumors, lymphomas, and … WebApr 10, 2024 · Even though platinum-based drugs such as cisplatin and carboplatin are effective in TNBC patients, their toxicity and development of cancer drug resistance often hamper their clinical use. Hence, novel drug entities with improved tolerability and selectivity profiles, as well as the ability to surpass resistance, are needed. high waist mom jeans black
NCBI Bookshelf
WebSep 3, 2015 · Introduction of cisplatin based chemotherapy has revolutionized the treatment of germ cell tumors. A common side effect of multiday cisplatin chemotherapy is severe nausea and vomiting. Considerable progress has been made in the control of these side effects since the introduction of cisplatin based chemotherapy in the 1970s. WebMar 15, 2024 · Cisplatin is a bedrock of cancer management and one of the most used chemotherapeutic agents in the treatment of germ cell, lung, bladder, ovarian, and head and neck cancers. Approximately 500,000 patients diagnosed annually with these cancer types in the United States could be candidates for treatment with cisplatin. WebMar 1, 2024 · Postoperative chemoradiotherapy with 3-weekly cisplatin at 100 mg/m 2 is standard treatment for patients with high-risk factors for recurrence. 2-4 However, the 3 … how many essays did john locke write